Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1035 | 1035 | 883 | 746 | 1441 | - |
Fund Return | 3.47% | 3.47% | -11.71% | -9.3% | 7.58% | - |
Place in category | 76 | 76 | 69 | 136 | 72 | - |
% in Category | 13 | 13 | 14 | 41 | 35 | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 36.88B | -14.94 | -21.26 | - | ||
Zhongou Medical and Health Hybrid C | 36.88B | -15.11 | -21.89 | - | ||
Lombarda China New Blue Chip Flexib | 8.87B | 1.70 | -7.45 | 12.46 | ||
Zhong Ou China New BlueChip Al HybE | 8.87B | 1.70 | -7.45 | - | ||
Lombarda China New Trend Hybrid Fun | 5.91B | 3.47 | -7.40 | 13.78 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TianHong ChiNext Index A | 6.81B | -3.60 | -11.88 | - | ||
TianHong ChiNext Index C | 6.81B | -3.65 | -12.06 | - | ||
ICBC Credit Literary Ids Eq | 5.51B | 2.65 | -7.47 | - | ||
Harvest Emerging Industry Eq | 5.46B | -6.83 | -16.49 | - | ||
RT SZSE 100 Index Fund A\B | 4.07B | 0.35 | -12.79 | 5.95 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Wanhua Chemical | CNE0000016J9 | 5.92 | 90.33 | -0.59% | |
Muyuan Foodstuff A | CNE100001RQ3 | 5.32 | 46.95 | +0.26% | |
Luxshare Precision A | CNE100000TP3 | 4.41 | 29.82 | +0.74% | |
China CSSC | CNE000000W05 | 4.01 | 38.25 | +2.79% | |
Zijin Mining A | CNE100000B24 | 3.47 | 17.71 | +1.49% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review